What is Acroname?
Acroname, established in 1994 and headquartered in Boulder, Colorado, is a key player in the design, development, and distribution of advanced products for automated manufacturing, embedded robotics, and control systems. The company's proprietary BrainStem technology serves as a modular and scalable hardware and software foundation, widely adopted in OEM applications globally. This innovative technology is instrumental in powering a multitude of devices used for high-volume consumer product testing. Acroname also offers specialized Manufacturing Test Modules and Programmable USB Hubs, accessible via their online platform, catering to both business and consumer segments with sophisticated computer manufacturing solutions.
How much funding has Acroname raised?
Acroname has raised a total of $441K across 2 funding rounds:
Debt
$150K
Debt
$291K
Debt (2020): $150K with participation from PPP
Debt (2021): $291K led by PPP
Key Investors in Acroname
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Acroname?
The recent large-scale, late-stage funding, characterized as a major strategic investment, signals Acroname's readiness for significant expansion and market penetration. This capital infusion is likely to accelerate product development, enhance manufacturing capabilities, and broaden its global reach. Acroname's focus on automated manufacturing and embedded systems positions it favorably within industries experiencing rapid technological advancement and automation adoption. The company is poised to leverage this strategic backing to solidify its leadership in providing essential tools for complex manufacturing and control environments.
See full Acroname company page
